Nabilone in Cannabis Users With PTSD
NCT03251326, Phase 1, Phase 2, Terminated, New York State Psychiatric Institute; results first posted 2020-10-12
Trial 11
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Nabilone in Cannabis Users With PTSD | ClinicalTrials.gov |
| NCT number | NCT03251326 | ClinicalTrials.gov |
| Status | Terminated | ClinicalTrials.gov |
| Phases | Phase 1, Phase 2 | ClinicalTrials.gov |
| Enrollment | 4 participants, actual | ClinicalTrials.gov |
| Lead sponsor | New York State Psychiatric Institute | ClinicalTrials.gov |
| Conditions | Cannabis, Post Traumatic Stress Disorder | ClinicalTrials.gov |
| Interventions | Nabilone, Cannabis, Propranolol, Placebo | ClinicalTrials.gov |
| First posted | 2017-08-16 | ClinicalTrials.gov |
| Last updated | 2022-07-15 | ClinicalTrials.gov |
| Results first posted | 2020-10-12 | ClinicalTrials.gov |
Registered outcomes 1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Cue Reactivity (Emotional Stroop Task) | 1 month | We cannot provide data as the study was terminated due to lack of feasibility. The staff responsible for data collection, organization, and cleaning have left the institution; we have made every effort to locate the data for the two participants who completed the study, but have been unsuccessful. We do not have access to the data. | ClinicalTrials.gov |
Outcomes 1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|---|---|---|---|---|---|
| PRIMARY | Cue Reactivity (Emotional Stroop Task) | 1 month | We cannot provide data as the study was terminated due to lack of feasibility. The staff responsible for data collection, organization, and cleaning have left the institution; we have made every effort to locate the data for the two participants who completed the study, but have been unsuccessful. We do not have access to the data. | ClinicalTrials.gov |
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|---|---|---|---|---|
| Overall Study | STARTED | Active Nab > Plac Prop > Plac Cann | 1 | ClinicalTrials.gov | |
| Overall Study | STARTED | Plac Nab > Act Prop > Plac Cann | 1 | ClinicalTrials.gov | |
| Overall Study | STARTED | Plac Nab > Plac Prop > Act Cann | 1 | ClinicalTrials.gov | |
| Overall Study | STARTED | Plac Nab > Plac Prop > Plac Cann | 1 | ClinicalTrials.gov | |
| Overall Study | COMPLETED | Active Nab > Plac Prop > Plac Cann | 1 | ClinicalTrials.gov | |
| Overall Study | COMPLETED | Plac Nab > Act Prop > Plac Cann | 1 | ClinicalTrials.gov | |
| Overall Study | COMPLETED | Plac Nab > Plac Prop > Act Cann | 0 | ClinicalTrials.gov | |
| Overall Study | COMPLETED | Plac Nab > Plac Prop > Plac Cann | 0 | ClinicalTrials.gov | |
| Overall Study | NOT COMPLETED | Active Nab > Plac Prop > Plac Cann | 0 | ClinicalTrials.gov | |
| Overall Study | NOT COMPLETED | Plac Nab > Act Prop > Plac Cann | 0 | ClinicalTrials.gov | |
| Overall Study | NOT COMPLETED | Plac Nab > Plac Prop > Act Cann | 1 | ClinicalTrials.gov | |
| Overall Study | NOT COMPLETED | Plac Nab > Plac Prop > Plac Cann | 1 | ClinicalTrials.gov |
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 12
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|---|---|---|---|
| Total, all-cause mortality | Active Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, all-cause mortality | Plac Nab > Act Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, all-cause mortality | Plac Nab > Plac Prop > Act Cann | 0 | 0 | ClinicalTrials.gov |
| Total, all-cause mortality | Plac Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, other adverse events | Active Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, other adverse events | Plac Nab > Act Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, other adverse events | Plac Nab > Plac Prop > Act Cann | 0 | 0 | ClinicalTrials.gov |
| Total, other adverse events | Plac Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, serious adverse events | Active Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, serious adverse events | Plac Nab > Act Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
| Total, serious adverse events | Plac Nab > Plac Prop > Act Cann | 0 | 0 | ClinicalTrials.gov |
| Total, serious adverse events | Plac Nab > Plac Prop > Plac Cann | 0 | 0 | ClinicalTrials.gov |
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|---|---|---|---|---|---|
| U54DA037842 | Shared Pharmacotherapeutic Strategies for Cannabinoid & Opioid Use Disorders | LEVIN, FRANCES RUDNICK | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC | NATIONAL INSTITUTE ON DRUG ABUSE | 2014 to 2018 | NIH RePORTER |
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Emotional Stroop Task | Primary outcome | ConductCognition |
| Food Cue Reactivity Task | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)